Erythromycin warnings and precautions: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Erythromycin}} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AKNE-MYCIN (ERYTHROMYCIN) OINTMENT [CORIA ...")
 
No edit summary
 
(One intermediate revision by the same user not shown)
Line 3: Line 3:
{{CMG}}; {{AE}} {{chetan}}
{{CMG}}; {{AE}} {{chetan}}


==Warnings==


The safe use of Akne-mycin during pregnancy or lactation has not been established.


<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = AKNE-MYCIN (ERYTHROMYCIN) OINTMENT [CORIA LABORATORIES] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=720512c7-9ea4-40c8-b119-b39a3f9a448b | publisher =  | date =  | accessdate =  }}</ref>
==Precautions==
Akne-mycin is for topical use only and should be kept out of the eyes, nose and mouth.
 
The use of antibiotic agents may be associated with the overgrowth of antibiotic resistant organisms. If this occurs, administration of the drug should be discontinued and appropriate measures taken.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = AKNE-MYCIN (ERYTHROMYCIN) OINTMENT [CORIA LABORATORIES] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=720512c7-9ea4-40c8-b119-b39a3f9a448b | publisher =  | date =  | accessdate =  }}</ref>


==References==
==References==

Latest revision as of 22:54, 8 January 2014

Erythromycin
AKNE-MYCIN® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Warnings

The safe use of Akne-mycin during pregnancy or lactation has not been established.

Precautions

Akne-mycin is for topical use only and should be kept out of the eyes, nose and mouth.

The use of antibiotic agents may be associated with the overgrowth of antibiotic resistant organisms. If this occurs, administration of the drug should be discontinued and appropriate measures taken.[1]

References

  1. "AKNE-MYCIN (ERYTHROMYCIN) OINTMENT [CORIA LABORATORIES]".

Adapted from the FDA Package Insert.